Related Articles
Proteasome inhibition by bortezomib does not translate into efficacy on two malignant glioma xenografts
Dyclonine enhances the cytotoxic effect of proteasome inhibitor bortezomib in multiple myeloma cells
The mechanism of cross-resistance to proteasome inhibitor bortezomib and overcoming resistance in Ewing's family tumor cells
Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell line
Bortezomib and etoposide combinations exert synergistic effects on the human prostate cancer cell line PC-3